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We describe the development and clinical evaluation of an automated smartphone-linked sensor 
capable of chemical-free, quantitative measurement of hemoglobin concentration ([Hb]) in whole blood 
samples. We have demonstrated that our sensor could analyze an unprocessed blood specimen with 




AG, Germany) and a portable hemoglobinomteter (Hb201+, Hemocue, Sweden). the sensor yielded 
comparable sensitivities and specificities of 87.50% and 100.00% for males, and 94.44% and 100.00% 
for females, respectively, for anemic detection. the results suggested that our optical sensor based on 
the intrinsic photothermal response of Hb molecules and advances in consumer electronics, particularly 
smartphone capabilities, enables a direct, chemical-free [Hb] assay accessible to people in both 
developed and developing countries.
Hemoglobin (Hb) constitutes approximately 96% of red blood cells and is responsible for carrying and transport-
ing oxygen to the organs through the circulatory system. The mass concentration of hemoglobin ([Hb]) therefore 
could be employed as a critical indicator of the oxygen-carrying capacity of blood, and its measurement is rou-
tinely performed as a significant and common task in blood assay.
One of the most emblematic blood disorders that can be diagnosed by [Hb] is anemia. In 2015, Global Burden 
of Disease1 reported 2.36 billion individuals to be inflicted with anemia globally, and more than half of them, 
which corresponds to 1.48 billion individuals, suffered from iron-deficiency anemia. The normal [Hb] range 
differs by race and age; however, males and females with [Hb] smaller than 13.0 g/dL and 12.0 g/dL, respectively, 
are generally classified as anemic2. Significant modulations in [Hb] might also indicate cardiovascular diseases3–7, 
neurological disorders8, dental disorders9, excretory disorders10, metabolic changes, hepatobiliary diseases, or 
endocri,ne disorders11. [Hb] is also an indicator of oxygen homeostasis; thus, [Hb] assay is carried out during or 
prior to blood transfusion, blood donation12 or surgery13. A sudden [Hb] change may also be an indicative of a 
stroke incident in women14, sudden loss of blood or regular bleeding15.
Representative [Hb] detection methods generally employ chemicals for hemolysis and subsequent genera-
tion of hemoglobin-related complexes are detected by colorimetric detectors. The exemplary methods involve 
the generation of hemiglobincyanide16, azide-methemoglobin17, and sodium lauryl sulfate-methemoglobin18. 
Clinical grade hematology analyzers and portable hemoglobinometers are mostly based on such protocols. While 
these methods enable high-accuracy and high-precision [Hb] measurement, some of the employed chemicals 
are hazardous to human and environment, and therefore the sensors are typically operated by trained opera-
tors in controlled sites such as clinical labs. Hematology analyzers enable comprehensive blood assays, but the 
instruments are expensive, laboratory-based, and require a large volume of blood (>150 µL). On the other hand, 
portable point-of-care (POC) hemoglobinometers such as Hb201 + (Hemocue, Sweden) and HemoControl (EKF 
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Diagnostics, UK) are relatively inexpensive and simple to operate. Yet, they require long operation time (~15–
60 s), toxic chemicals such as potassium cyanide, and large blood volume (>10 µL).
Several chemical-free [Hb] detection technologies have recently been developed. The [Hb] detector based 
on WHO hemoglobin color scale (HCS) is simple and inexpensive, but its measurement is not quantitative and 
accurate, and also requires large volume of blood (20 µL)19. An automated Hb sensor based on HCS has been 
introduced capable of operating on a smartphone20. However, its operation requires chemicals for reliable oper-
ation. Several [Hb] sensing methods that exploit intrinsic physical properties of Hb have been developed. The 
iron oxide inside hemoglobin exhibits high absorbance at 520–540 nm, and therefore it generates heat under 
the 532-nm light illumination21–24. The resultant temperature increase can be quantitatively measured and con-
verted into [Hb] through electronic and optical transducers. The micro-patterned resistive temperature sensors25 
have demonstrated high-accuracy detection of [Hb]. However, each measurement requires a dedicated detec-
tion chip patterned with temperature sensors and electrodes, which altogether may increase the cost per assay. 
Several optical methods have been demonstrated. These methods utilize the modulation of refractive index (RI) 
of blood samples due to photo-thermal (PT) response of Hb molecules under the PT excitation light source. 
Spectral-domain optical coherence reflectometer demonstrated highly accurate [Hb] detection, but its optical 
interferometric configuration may pose some issues and challenges in terms of stability and miniaturization26,27. 
Photo-thermal angular scattering (PTAS) also exploits high sensitivity of angular scattering spectroscopy to 
photo-thermal RI modulations under the illumination of PT light28. Compared to others, this method is highly 
attractive in that it is rapid and requires extremely small volume of blood (<1 µL), which significantly reduces 
user pains and potential phlebotomy contamination29.
Here, we revisit PTAS technology and present a portable, smartphone-linked [Hb] sensor capable of 
high-accuracy [Hb] assay. We transformed PTAS into a portable and light-weight sensor that can be built with 
inexpensive consumer electronic devices and operated with any mobile device, such as a smartphone. The sensor, 
termed mobile-PTAS (“m-PTAS”), features 58 × 68 × 156 mm3 in size, and enables chemical-free [Hb] assay with 
a blood volume of <150 nL. Therefore, it is user- and environment-friendly, and its operating cost is estimated 
to be <0.20 USD. The m-PTAS sensor was calibrated with reference to a clinical grade hematology analyzer 
(ADVIA 2120i, Siemens AG, Germany) by using 16 fresh blood samples from healthy volunteers and patients. 
We then assessed its relative accuracy and precision and compared the results with those of a hematology analyzer 
(ADVIA 2120i, Siemens AG, Germany). The results were further compared against those from a representative 
hemoglobinometer (Hb201+, Hemocue, Sweden) to assess its reliability as a portable POC hemoglobinometer. 
Diagnostic capability of anemic bloods was also evaluated and compared against the results of reference detectors.
Results
m-ptAS module. The m-PTAS module was developed to perform direct, rapid and chemical-free [Hb] assay 
on a smartphone platform (Fig. 1A). The m-PTAS had dimensions of 52 × 66 × 156 mm3 and weighed ~250 g. 
For [Hb] assay, blood is loaded into a capillary tube via capillary action. The required volume for measurement 
is approximately measured to be <150 nL. The module is connected to a smartphone and the blood-loaded 
capillary tube is positioned into the V-mount inside the module (Fig. 1B). The lid of the module is closed, and 
the module is switched on. The PTAS App, named as ‘meaHb’, is then run using the smartphone (Fig. 1C,D). The 
smartphone application was developed for operation in Android OS. However, it should be noted that the appli-
cation can be readily implemented on iOS platform. The application acquires the time-lapse images of scattering 
patterns under illumination of probe and PT lights for 5 s, and computes and displays the [Hb] of the blood sam-
ple (Methods and materials for details). Operation of m-PTAS module is presented in Supplementary Movie S1.
m-ptAS sensor calibration. Calibration of m-PTAS sensor was performed with sixteen whole blood speci-
mens of various [Hb] (0.1 g/dL–17.8 g/dL). Fourteen blood samples ([Hb] from 4.8 g/dL to 17.8 g/dL and plasma) 
were directly obtained from a clinical laboratory, and two samples of low [Hb] ([Hb] = 1.65 g/dL and 3.1 g/dL) 
were created by diluting a 6.2 g/dL blood sample with autoplasma. [Hb] of sixteen specimens and their corre-
sponding m-PTAS sensor signals are listed in Supplementary Table S1. The m-PTAS measurements were carried 
out ten times for each sample, and the outputs were compared against the [Hb] values from a reference hema-
tology analyzer that was calibrated with dedicated calibrators (ADVIA 2120i, Siemens AG, Germany). Figure 2 
presents the calibration curve.
As can be noted, m-PTAS sensor exhibited a nonlinear response as a function of [Hb], which agrees to the the-
oretical estimation made by Gemert et al.30 Such behavior in the calibration data has been successfully fitted with 
a Hill equation27,31. We performed a curve fitting of m-PTAS calibration results with a Hill equation (R2 > 0.99)32. 
The fitting function and its coefficients are listed in Supplementary Table S2. The error bar denotes a 95% confi-
dence interval (CI).
m-ptAS detection limit. Detection limit of m-PTAS sensor was examined under the guideline EP17, 
Protocols for Determination of Limits of Detection and Limits of Quantitation published by Clinical Laboratory 
Standards Institute (CLSI)33,34 to obtain limit of blank (LoB), limit of detection (LoD), and limit of quantitation 
(LoQ) (Table 1). For this evaluation, a blood sample of [Hb] = 9.5 g/dL and autoplasma were used to produce 
blank and blood samples of low Hb concentrations.
For LoB quantification, we employed the plasma that was obtained by centrifuging 9.5 g/dL blood sample as 
the blank. We performed sixty m-PTAS measurements of the samples and the arithmetic mean of the sensor out-
puts was obtained as LoB = 0.0039 g/dL. In order to quantify LoD, a blood sample of [Hb] = 0.03 g/dL (measured 
by ADVIA 2010i analyzer) was created by diluting 9.5 g/dL blood with autoplasma, and its [Hb] was measured 
sixty times by the m-PTAS sensor. We computed the standard deviation (SD) of the measurements, and then 
evaluated LoD as LoD = LoB + 1.645×SD = 0.0471 g/dL, as instructed by EP 17. Blood samples of five different 
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Figure 1. m-PTAS module. (A) m-PTAS sensor. (B) A user places a blood-loaded capillary tube into a slot in 
the m-PTAS module. Shown in inset is the magnified view of the capillary tube positioned inside the device. 
(C,D) The device lid is closed, and a dedicated smartphone application (“meaHb”) computes and displays [Hb] 
on a smartphone.
Figure 2. m-PTAS sensor calibration curve. The m-PTAS sensor outputs were calibrated against [Hb] 
measured by a reference hematology analyzer (ADVIA 2120i, Siemens AG, Germany). Sixteen blood samples of 
[Hb] ranging from 0.1 g/dL to 17.8 g/dL were analyzed (see Table S1 for detailed information). Each sample was 
measured ten times, and the error bar denotes 95% confidence interval (CI). The measurement was fitted with a 
Hill equation (R2 > 0.99). Curve fitting constants are given in Table S2.
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Hb concentrations were also prepared. The m-PTAS measurements were performed ten times for each sample, 
and their CVs were evaluated. As guided by EP 17, the measurement results of blood samples of [Hb] = 0.095 g/
dL and 0.1188 g/dL were utilized to compute LoQ, as their mean CV value was closest to 20%. The LoQ was then 
computed as the arithmetic mean of two measurements, yielding LoQ = 0.1069 g/dL.
m-ptAS precision. We quantified [Hb] measurement precision of the m-PTAS sensor using two quality 
control (QC) samples provided by Siemens (ADVIA 120/2120/2120i 3 in 1 TESTpoint Hematology Controls, 
10316217 and 10318905, Siemens AG, Germany). The [Hb] values of the QC specimens were provided as 11.2 g/
dL and 16.4 g/dL by the manufacturer.
In order to evaluate intra-assay imprecision, we performed repeated measurements of the same specimen 
on the same day. The inter-assay imprecision was, on the other hand, evaluated by measuring [Hb] of the dif-
ferent sample (but with the same Hb concentration) for five days. The measurements were performed five times 
per sample. For inter-assay evaluation, we adopted EP15-A2 guides recommended by The Clinical Laboratory 
Standards Institute (CLSI)35. The results are summarized in Table 2. Intra-assay imprecision exhibited coefficient 
of variation (CV) of 1.21% at [Hb] = 11.2 g/dL with standard deviation (SD) of 0.14 g/dL. At [Hb] = 16.4 g/dL, 
CV was computed as 1.65% and SD was measured as 0.27 g/dL. For inter-assay imprecision, at [Hb] = 11.2 g/dL, 
CV was calculated as 2.14% with the measured SD of 0.24 g/dL. At [Hb] = 16.4 g/dL, CV was calculated as 1.76% 
with the measured SD of 0.29 g/dL.
Note that Hb201+ provides intra-assay CV of 0.71% with SD of 0.11 g/dL at [Hb] = 15.36 g/dL, while ADVIA 
2120i offers CV of 0.93% with SD of 0.14 g/dL at [Hb] = 15.0 g/dL. These results indicate that m-PTAS exhibits 
high reproducibility, comparable to ADVIA 2120i and Hb201+.
m-ptAS relative accuracy. High-accuracy [Hb] detection capability of m-PTAS was then evaluated by 
measuring [Hb] of 250 blood samples from clinics and by comparing the results against those of the reference 
hematology analyzer (ADVIA 2120i, Siemens AG, Germany). The performance of m-PTAS sensor was also 
compared against that of a representative POCT hemoglobinometer (Hb201+, HemoCue, Sweden). The blood 
samples exhibited randomly distributed [Hb] ranges of 5.2 g/dL–20.6 g/dL. Detailed information of the blood 
specimens is provided in Supplementary Table S3.
Figure 3A presents Passing-Bablok regression36 for [Hb] results from m-PTAS and the ADVIA 2120i analyzer. 
The blue line indicates a linear regression line, and black solid and red dashed lines represent identical line and 
95% confidence band, respectively. The linear regression line is characterized by an intercept of −0.1648 with 
Analysis Category Specimen Type Specimen[Hb] (g/dL)
m-PTAS Sensor Limit of 
Blank (g/dL)Mean (rad) SD (rad) Measurement
Limit of Blank Plasma 0.0000 0.0469 0.2811 60 0.0039
Analysis Category Specimen Type Specimen[Hb] (g/dL)
m-PTAS Sensor




Limit of Detection Diluted Blood Specimen 0.0316 0.0371 0.0263 60 0.0471
Analysis Category Specimen Type Specimen[Hb] (g/dL)
m-PTAS Sensor








0.0475 0.0492 0.0205 41.74 10
0.1069
0.0950 0.0877 0.0237 27.04 10
0.1188 0.1229 0.0201 16.36 10
0.1900 0.1872 0.0224 11.98 10
0.2375 0.2529 0.0265 10.49 10
Table 1. m-PTAS sensor detection performance. Detection performance of m-PTAS sensor was quantified 
based on EP17 guidelines. Diluted blood samples with low [Hb] for LoB and LoQ evaluation were created using 





















11.2 g/dL 11.24 0.14 1.21 11.19 0.24 2.14
16.4 g/dL 16.45 0.27 1.65 16.45 0.29 1.76
Table 2. m-PTAS intra- and inter-assay imprecisions. Quality control (QC) samples from Siemens were used to 
assess m-PTAS precision.
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95% confidence interval (CI) of −0.3600 to 0.0225 and the slope of 1.0328, with 95% CI ranging from 1.0141 to 
1.0500. These results indicate an excellent agreement between the results from ADVIA 2120i and m-PTAS sensor, 
with a correlation coefficient (r) of 0.991. The R2 and root-mean-square error (RMSE) were computed as 0.9810 
and 0.5368 g/dL. This result suggests that measurements from the reference hematology analyzer and m-PTAS 
sensor are in agreement without significant discrepancy. Similar analysis was also performed for Hb201+ against 
the hematology analyzer (Fig. 3B). The same blood samples listed in Supplementary Table S3 were used for the 
evaluation. The intercept and slope of the linear regression were found to be −0.2243 and 1.0450, and the corre-
sponding 95% CIs were −0.3824 to −0.0781 and 1.0312 to 1.0588, respectively. The results also indicate a great 
correspondence between ADVIA 2120i and Hb201 + (r = 0.989, R2 = 0.9791 and RMSE = 0.5857 g/dL).
Bland-Altman analysis was further carried out for m-PTAS and Hb201+ against the hematology analyzer, 
ADVIA 2120i (Fig. 3C,D)37. Measurements from m-PTAS and ADVIA 2120i exhibited a mean bias of −0.2496 g/
dL with 95% CI ranging from −0.3091 g/dL to −0.1901 g/dL. The standard deviation (SD) was 0.4796 g/dL 
with limits of agreement (LOAs) ranging from −1.1853 g/dL to 0.6861 g/dL. 95% CI of lower limit ranged from 
−1.2870 to −1.0835, whereas that for upper limit ranged from 0.5843 to 0.7878. No systematic difference between 
two measurements was found. Overall, 92.8% of the m-PTAS measurements corresponded to those from ADVIA 
2120i within [Hb] difference of 1.0 g/dL. Figure 3D shows the Bland-Altman analysis for the measurements from 
ADVIA 2120i and Hb201+. The mean bias was measured as −0.2836 g/dL with 95% CI ranging from −0.3476 g/
dL to −0.2196 g/dL. SD between the measurements was 0.5102 g/dL and LOA ranged from −1.2900 g/dL to 
0.7228 g/dL. 95% CI of lower bound ranged from −1.3994 to −1.1805 and 95% CI of upper bound ranged from 
0.6133 to 0.8322. The analysis found no systematic difference or bias, and overall, 91.6% of Hb201+ measure-
ments corresponded to the results from ADVIA 2120i within [Hb] difference of 1.0 g/dL.
m-ptAS based anemic assay. Iron-deficiency anemia is one of the most significant disorders that can 
be diagnosed by assessing [Hb]. In order to demonstrate clinical significance of m-PTAS, we assessed the detec-
tion performance of m-PTAS for anemia. Prior to this evaluation, [Hb] of 142 blood specimens were measured 
(Supplementary Table S4), and classified into anemic and non-anemic by ADVIA 2120i analyzer with their gen-
der information considered. For anemia diagnosis, clinical cut-offs suggested by World Health Organization 
(WHO) was employed; anemia is defined by the WHO as a [Hb] below 13.0 g/dL for males and below 12.0 g/dL 
Figure 3. m-PTAS relative accuracy. Passing-Bablok regression analyses for the [Hb] values obtained from (A) 
ADVIA 2120i and m-PTAS, and (B) ADVIA 2120i and Hb201+. Solid blue lines represent linear regression 
lines, and black dash lines represent identical lines. Two red dashed lines represent the confidence band. Bland-
Altman analyses for the [Hb] values from (C) ADVIA 2120i and m-PTAS, and (D) ADVIA 2120i and Hb201+. 
Black dashed lines represent no difference, and solid blue lines represent mean bias. Two red dashed lines 
represent 95% limits of agreement. The green error bar represents 95% CI of ± 1.96 SD.
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for females38. Figure 4A,B present m-PTAS classification results based on this clinical cut-offs. Red dashed line 
refers to the clinical cut-off of [Hb] = 13.0 g/dL for males and [Hb] = 12.0 g/dL for females. The m-PTAS diag-
nosed anemia with 93.15% and 97.10% accuracies for males and females, respectively. The measured sensitiv-
ities and specificities were 87.50% and 100.00% for males, and 94.44% and 100.00% for females, respectively. 
Figure 4C,D show the classification results from Hb201+. Hb201+ classified anemic blood samples with 94.52% 
and 95.65% accuracies for males and females, respectively. The corresponding sensitivities and specificities were 
computed as 90.00% and 100.00% for males, and 91.67% and 100.00% for females. Results of statistical analyses 
are provided in Supplementary Table S5.
Discussion
The m-PTAS sensor provides rapid, simple, inexpensive, and disposable self-screening and self-monitoring capa-
bility for [Hb] and [Hb]-related blood disorders (e.g., anemia), requiring only <150 nL of blood sample. The 
notable features are (a) chemical-free operation, enabling safe and environment-friendly [Hb] assay; (b) low 
cost for [Hb] assay (each measurement requires a small and disposable capillary tube, which costs <0.20 USD); 
(c) small size and portability; and (d) ease of use (a dedicated smartphone app enables users to measure [Hb] 
themselves).
Our sensor is characterized by high precision with its intra and inter-assay precisions of 1.65% and 1.76% 
at [Hb] = 16.4 g/dL respectively. A clinical evaluation based on fresh whole blood suggested that [Hb] results 
from m-PTAS sensor exhibits a high correlation with those of an automated hematology analyzer, ADVIA 2120i 
(r = 0.991), and yielded excellent sensitivity, specificity and accuracy for anemia detection (sensitivity: 87.50%, 
specificity: 100.00%, and accuracy: 93.15% for males; sensitivity: 94.44%, specificity: 100.00%, and accuracy: 
97.10% for females). Its performance was comparable to that of a representative portable hemoglobinometers, 
Hb201 + (correlation coefficient: 0.989; sensitivity: 90.00%, specificity: 100.00%, and accuracy: 94.52% for males; 
sensitivity: 91.67%, specificity: 100.00%, and accuracy: 95.65% for females).
Our smartphone-linked m-PTAS sensor is capable of rapid, automated and quantitative [Hb] analysis, 
and requires no technical expertise to operate. Therefore, the sensor could be utilized as a convenient [Hb] 
assay device in local blood centers and for anemia self-screening, especially for those with anemia or other 
Figure 4. Comparisons of anemia classification results from (A,B) ADVIA 2120i and m-PTAS, and (C,D) 
ADVIA 2120i and Hb201+. (A,C) are the anemia classification results for males, and (B) and (D) are those for 
females. The red dashed lines represent clinical anemia cut-offs ([Hb] = 13.0 g/dL for males and [Hb] = 12.0 g/
dL for females).
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blood-related disorders. In specific, patients susceptible to chronic anemia, including cancer patients undergoing 
chemotherapy, may utilize this device to monitor their [Hb] at convenience and transmit the results to primary 
care physicians if their [Hb] levels vary abnormally from the normal baseline. Finally, as our sensor requires an 
extremely small amount of blood (<150 nL), this device might work with other blood extraction technologies 
such as laser needle39, minimizing blood loss especially for neonates and children.
In terms of m-PTAS implementation, it should be noted that the physical size and cost of m-PTAS module can 
be further reduced. In our present setup, we employed the complimentary metal-oxide semiconductor (CMOS) 
image sensor of 1/2.7” type, which features 5.27 × 3.96 mm2 in size, to capture a large number of angular scat-
tering patterns on the detector. The measurement of the large number of scattering fringes improves signal to 
noise ratio and sensitivity of our Fourier-based analysis. Yet, it required the use of optical filters and mirrors of 1” 
diameter and 0.5” diameter respectively in our case. It should be noted that further miniaturization of m-PTAS 
sensor can be achieved by use of smaller image sensor and optical elements. In this case, the number of angular 
scattering fringes may be reduced that can be measured by the detector, but by placing multiple high-power PT 
micro-LEDs proximal to a blood-loaded capillary, the larger PT response can be induced, thereby improving 
sensitivity. Instead of multiple optical filters, a customized optical filter directly on top of CMOS sensor may be 
conceived. These modifications would be a more efficient avenue for future productization. The computation 
time for [Hb] in the present m-PTAS is determined largely by the central processing unit (CPU) of smartphone, 
which performs all the computations with images and Fourier analysis. In this demonstration, the computation 
time was measured to be 2.29 s with a standard deviation of 0.06 s on the platform of Samsung Galaxy S8. Various 
parallel computational strategies compatible with graphics processing unit may be considered to further improve 
the computation time.
We demonstrated our m-PTAS sensor in a platform of smartphone to exploit several attractive features and 
functions provided by the smartphone; it can perform PTAS image processing, conversion of m-PTAS sensor out-
puts into [Hb] values, display and saving of the [Hb] results, and wireless transfer of the results to remote sites, if 
necessary. However, it should be noted that the acquired angular scattering images from the m-PTAS module can 
be transferred to and processed in any types of mobile devices and computers equipped with USB connectivity 
(e.g., PC, micro PC). The device can also be implemented as the stand-alone [Hb] detector, with dedicated digital 
signal processing board and display module inside the device. Taken these features together, m-PTAS is expected 
to be a viable POC hemoglobinometer with demonstrated diagnosing performance.
Materials and methods
m-ptAS sensor operation. Optical and electronic architectures of PTAS were re-designed, optimized, and 
engineered to transform PTAS into a portable, robust and smartphone-linked [Hb] sensor platform, m-PTAS. 
Its operation is illustrated in Supplementary Fig. S1. A blood-loaded capillary tube is illuminated by a 650-nm 
probe light, the wavelength of which is outside the Hb absorption range. The incident light is then refracted 
and scattered by the tube and blood components, and the interference of the scattered light produces a distinct 
semi-periodic pattern on a detector array. This scattering pattern is found to be highly sensitive to the refractive 
index of specimen in tube and physical size of the tube40,41. The theoretical analysis for this angular scattering 
pattern can be found elsewhere42.
In order to perform chemical-free [Hb] assay via angular light scattering, we exploited intrinsic PT response 
of Hb molecules. Hb molecules exhibit high absorption at around 520–540 nm, and thus upon the illumination 
of 532-nm light, Hb molecules inside the capillary tube absorb the incident light energy and convert it into 
heat21–24. The resultant temperature rise decreases the refractive index (RI) of the blood inside the tube43, which 
subsequently shifts the angular light scattering pattern (Supplementary Movie S2). We observed that the amount 
of the scattering shift is proportional to the amount of hemoglobin in the blood, and thus we quantified the shift 
of the angular scattering pattern to perform quantitative [Hb] assay. For measurement, we acquired time-lapse 
images of scattering patterns at a frame rate of 30 Hz for 5 s under the intensity modulated PT light illumination. 
We employed intensity-modulated illumination for the PT light, as it facilitated measurements with high signal 
to noise ratio (SNR). The modulation frequency was set to 1 Hz.
We computed m-PTAS sensor output as detailed in Kim et al.28 Supplementary Fig. S2 outlines the signal pro-
cessing method. For each image frame, we obtained an averaged scattering pattern by calculating the mean of the 
pixel values of the image along the vertical direction. Supplementary Figs. S2A and S2B present exemplary images 
and corresponding averaged scattering patterns before and after PT light illumination. The measured scattering 
pattern was then Fourier transformed. Since the angular scattering pattern was characterized by a distinct spatial 
frequency, its Fourier counterpart could readily be located. We measured the phase of the scattering signal in the 
Fourier domain during the modulated PT light illumination. Supplementary Fig. S2C shows phase fluctuations 
during the modulated PT illumination. The measured phase fluctuation was then Fourier transformed, and its 
magnitude at the modulation frequency, termed the m-PTAS sensor signal, was examined (Fig. S2D).
m-ptAS fabrication. The main frame and opto-mechanical structures of the m-PTAS were designed using 
SolidWorks (Solidworks 2016, Dassault Systèmes SolidWorks Corp., France) and manufactured with a stereo 
lithography apparatus (SLA) based 3D printer (KINGS 3035 Pro SLA 3D Printer, Shenzhen Kings 3D Printing 
Technology, China). The base material was resin except for some add-in structures inside the module. Figure S3 
depicts the optical setup inside the module. 650-nm (650MD-1-0618, Besram Technology Inc., China) and 
532-nm (532MD-200-3*7 V, Lilly Electronics, China) laser diodes were employed as the probe and PT excitation 
light sources. The light from the laser diodes (LDs) illuminated and overlapped in a capillary tube (CV2033, 
CM Scientific, England), that features inner and outer diameters of 200 μm and 330 μm, respectively. Note that 
a 300-mm long capillary tube costs approximately 1.1 USD, and the required tube length for a reliable Hb assay 
was 50 mm in our device. Therefore, the 300-mm long tube was cut into 6 pieces, and the cost per each assay 
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was estimated to be 1.1 USD/6 = 0.18 USD (<0.20 USD). We placed a circular aperture (700 μm in diameter) in 
front of the probe LD to ensure that the probe light is smaller than the PT excitation light. The aperture was 3D 
printed (Wiiboox One, Measurement Korea, Republic of Korea). The beam spot sizes of the probe and PT light 
were measured to be 0.57 mm and 0.82 mm on the capillary tube. The intensity of the PT light was 90.5 mW/cm2.
The scattering pattern of the 650-nm probe light produced by the capillary tube was captured by a complimen-
tary metal-oxide semiconductor (CMOS) sensor (ELP-USBFHD01M-L21, Ailipu Technology Co., Ltd, China). 
The sensor is equipped with USB connection, through which the detector is powered, and data are transferred. 
In our device, the PT laser diode emitted light at 532-nm, 808-nm, and 1064-nm simultaneously. Hence, neu-
tral density (NE30B, Thorlabs, USA), long-pass (FGL610, Thorlabs, USA), and infrared cut-off filters (12.5 mm 
Diameter IR Cut-Off Filter, Edmund Optics Korea, Republic of Korea) were stacked and inserted in front of the 
image sensor to ensure detection of only 650-nm probe light without saturation. The module was 52 × 66 × 
156 mm3 in size. Detailed illustrations of 3D module frame and fully assembled m-PTAS sensor are presented in 
Supplementary Figure S4.
To achieve PTAS measurement with high SNR, the 532-nm PT laser was modulated at 1 Hz. The modulation 
was performed by Arduino-nano (SZH-EK025, Jiangsu Yuheng Co., Ltd, China) with pulse-width modulation 
(PWM) control.
The bill of materials for our m-PTAS implementation is provided in Supplementary Table S6. It should be 
emphasized that the cost can be further reduced by using high-power micro-LEDs, and smaller image sensor and 
optical elements.
Smartphone application. Our application is based on the Android platform, which provides various pro-
cessing features such as recording sensor data obtained from the external sensor devices connected through USB. 
In order to perform robust and computationally effective analysis, as described in m-PTAS sensor operation, we 
employed the following strategies and optimizations to our software implementation. The sequential image data 
were acquired from the CMOS sensor for 5 s, where the libusbcamera library44 was adopted. The sensor data 
acquisition and data processing procedures operated separately, instead of executing in parallel. This prevented 
the unintended interruption of the data acquisition process due to the computation constraints of the mobile 
device. Moreover, the multithreaded video decoding was employed to utilize all the CPU cores, and to maxi-
mize the computational power, C++ -based implementations were employed in several heavy operations such 
as image pre-processing.
We deployed our mobile application to a Samsung Galaxy S8 smartphone running on Android 8.0.0 oper-
ating system (OS). The device contains a Samsung Exynos 8895 system-on-chip (SoC), which consists of eight 
CPU cores. In addition, this device supports connection with an external sensor device through its USB 3.0 
Type-C port, which provides sufficient data bandwidth to receive images having a resolution of 1920 × 1080 
pixels at a frame rate of 30 Hz. Overall computation takes 2.29 s on average with a standard deviation of 0.06 s 
(Supplementary Table S7).
Sample preparation (iRB). This study was approved by the Institutional Review Board (IRB) of Severance 
Hospital (Seoul, Republic of Korea), an affiliated hospital of Yonsei University Health System (Approval Number: 
1-2016-0037). The clinical blood samples were residual blood samples that had been acquired and processed in 
clinical labs. The acquisition of written consent forms from the patients was waived for using the remaining blood 
samples after clinical laboratory tests under the IRB. All experiments were conducted in accordance with princi-
ples expressed in the Declaration of Helsinki or other relevant guidelines and regulations. The blood samples were 
supplemented with tripotassium ethylenediaminetetraacetate (K3EDTA) to prevent coagulation. For experiment, 
all the samples were obtained on the same day unless specified otherwise, and measured within three days. The 
samples were stored at room temperature (23 °C).
For m-PTAS calibration, fresh 16 blood specimens of different [Hb] (0.1 g/dL, 4.8 g/dL, 5.8 g/dL, 7.1 g/dL, 
8.0 g/dL, 9.0 g/dL, 10.0 g/dL, 11.0 g/dL, 12.0 g/dL, 13.0 g/dL, 14.0 g/dL, 15.0 g/dL, 16.0 g/dL, and 17.8 g/dL) were 
prepared. The samples of [Hb] = 0.35 g/dL and 1.5 g/dL were prepared by diluting the 6.2 g/dL blood sample with 
plasma gathered from centrifuged blood sample of [Hb]=13.1 g/dL. Other specimens were directly obtained 
from the clinical laboratory.
For LoB, LoD and LoQ quantification of m-PTAS sensor, the blank and blood samples of low Hb concen-
trations were all created by diluting 9.4 g/dL blood with autoplasma. Prior to m-PTAS assay, the [Hb]s of all the 
samples were measured by ADVIA 2010i analyzer. For precision test, two quality control (QC) samples from 
Siemens AG (ADVIA 120/2120/2120i 3 in 1 TESTpoint Hematology Controls, 10316217 and 10318905, Siemens 
AG, Germany) were used. [Hb] value of both samples, 11.2 g/dL and 16.4 g/dL respectively, were specified by the 
manufacturer.
For evaluation of relative accuracy, a total of 250 clinical blood samples from pediatric and adult patients 
were gathered, measured, and analyzed. For anemia assay, 142 blood samples with the gender information were 
gathered. [Hb] was measured by the clinical grade hematology analyzer (ADVIA 2120i, Siemens AG, Germany), 
a portable hemoglobinometer (Hb201+, Hemocue, Sweden), and m-PTAS. The [Hb] values from the automated 
hematology analyzer were not revealed to m-PTAS operators to ensure objective evaluation.
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